Skip to main content

R&D

Join WhatsApp Channel 

Regulatory Affairs Courses
  • Margdarshi Fellowships for visionary biomedical scientists by The Wellcome Trust-DBT India

    The Wellcome Trust/DBT India Alliance is an £80 million initiative funded equally by The Wellcome Trust, UK and Department of Biotechnology, India. The broad aim of the India Alliance is to build excellence in the Indian biomedical scientific community by supporting future leaders in the field. To achieve this we provide competitive Fellowships across the full spectrum of biomedical science: from fundamental biology through to clinical and public health research.

  • Wellcome Trust/DBT offers Senior Fellowships for Researchers in India

    This scheme supports outstanding researchers of any nationality, either medically qualified or science graduates, who wish to pursue a research career in an academic institution in India. Applicants must have demonstrated their ability to lead an independent research project and group.

    [adsense:336x280:8701650588]

  • Opening for Senior Research Fellow in Gautam Buddha University

  • Recruitment for the posts of Senior Scientist & Scientist for the THSTI - IAVI HIV Vaccine Design Program

    Translational Health Science and Technology Institute (THSTI) , India and the International AIDS Vaccine I nitiative (IAVI), USA have set up a collaborative program to accelerate and advance HIV vaccine research and development. The program is an integral part of the THSTI cluster of research centers and linked to global network of R&D facilities, including IAVIs Neutralizing Antibody Consortium (NAC) and IAVI Design and Development lab, situated in Brooklyn, New York.

  • Career for Research Associate in Piramal Lifesciences

    Piramal Life Sciences Limited (PLSL) is an independent research-driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited). PLSL was formerly the NCE R&D division of NPIL. PLSL has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai, India and over 300 scientists engaged in drug discovery and development.

  • Vacancy for Director - Cell Biology in United States Pharmacopeia

    The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements.

  • Multiple Vacancies for M.Pharm/M.Sc as ASST DIRECTOR, RESEARCH OFFICER, ASST RESEARCH OFFICER @ CCRH

    CCRH, an autonomous body under the Department of AYUSH, Ministry of Health and Family Welfare, Government of India intends to engage the following categories of personnel on contract basis for a period of 06 (six) months for Homoeopathic Pharmacopoeia Laboratory (HPL), Ghaziabad (Uttar Pradesh).

  • Vacancy for Group Lead R&D in Mylan

    Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.

  • Opportuniy for Junior EXECUTIVE R&D, Boiler Operator, Production Junior Executives in MNC Company for Formula HR Consulting | 30 Posts

    MNC Company for Formula HR Consulting

    Post: Junior Executive R&D, Boiler Operator, Production Jr Executives

    [adsense:336x280:8701650588]

  • Work as PRINCIPAL SCIENTIST - Analytical in Biocon

    Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
    Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Subscribe to R&D